Member Info for Globex

Looks like a pretty definitive reversal to me, delighted with my entry, still can't see any resistance between here and 50p

Yeah it's all a bit strange, he's so wound up about the company lol

In for the reversal, can't see much resistance between here and 50p

Davey you've only ever de-ramped on this share, so it's a bit rich to talking about both sides of the story. The one downside with these mega rises here is that it brings out these oddballs, clearly sour grapes so I do have a degree of sympathy for them.

No matter how furious their rants become the thing to never lose sight of is OBD have quite simply developed the most accurate test for prostate cancer on the planet - and it's commercially available right now. Anything that assists in any way in the fight against cancer can only be a good thing.

Frankly this has now inadvertently become a far bigger part of my portfolio than planned still but don't plan on selling a single share because I genuinely believe this is one of the biggest global biotech stories of the year.

The wider market is only waking up to this, and as more of the vast investment sums geared towards pharma get on board the momentum will become unstoppable.

Try using a proper broker

Yes Jimi they just raised £6.1m last month (at a premium) to fund it, so long cash runway.

Https://www.businesswire.com/news/home/20231003373303/en/Oxford-BioDynamics-Receives-Reimbursement-Code-for-EpiSwitch-Prostate-Screening-PSE-Test

Agree Spacerat, a good time to be bearish on this would have been any time before it dropped 50% in a few months. I was in early August when I clocked poor F1 Manager user feedback and posted as such at the time, while exiting that earlier trade - before company announced corresponding weaker outlook.

Now with the benefit of hindsight every man and his dog seems to be saying the end is nigh. This kind of retail despair can be a pretty good contrarian indicator.

What these calls at the lows miss is that it's no longer a growth play but a recovery/sum of parts one. Yes it may well fall further from here - momentum is currently against it - but if this was on someone's radar as an acquisition target, the dramatic drop in enterprise value will only have made it more attractive.

Meanwhile poor old Argo made a similar claim but no f-cks were given 😁

Once US funds come across this company and its progress we'll truly be cooking on gas. Can only be a matter of time, and today's certification won't have gone unnoticed by the sharper ones. Best part is OBD already have a US base so can deal with investor interest first hand.

To me Riot's electricity news looked like double counting, strange market lapped that up because trading a bit of leccy doesn't seem a key characteristic of a growth stock.

I guess market gives a lot of credit to their relatively strong balance sheet, but you'd think that would be offset taking into account their slow expansion. Mara can now make a pretty good claim to have a tidy balance sheet post bond recall but market didn't like that either 🤔. Optimistic that when Mara next reports financials market will start to catch up.

Aklee I actually believe a Nasdaq will be part of their longer term game plan. Unlike a lot of British companies that moan about being listed on the LSE even though most of their customers are based in the UK, OBD have a legitimate claim to switch. They already have a US office and new lab based there. We've seen benefit of that with this regulatory approval today.

Correction should say Riot is #1 market cap at end there, that valuation is the crackers thing

If you compare Cipher to Riot, which after all was the crux of my post, Cipher looks underrated in that comparison. Not just in terms of financials/mining output, but also general chatter across the internet. That lack of interest is what I was getting at by saying underrated rather referring to valuation alone.

But CLSK as you know I rate also. Not just based on a narrow valuation comparison to a single miner but in wider industry context, so it's certainly possible that both CLSK and Cipher are currently undervalued - that's the position I've taken.

To me the more interesting point is that Riot is still #2 market cap but this month for first time since 2021 has dropped to #4 for output.

To have this official marker in hand and so quickly is a big validation of the science. The fact they have a US lab and boots on the ground there seems to be really turbocharging getting this to patients.

Reardon take a look at the accounts mate, they reported a 17% drop in revenue I'm afraid. Then take a look at the outlook provided at full year and re-read my post

They've been a bit misleading with this line in opening section:

"Revenues in core brands declined 10%, consistent with prior guidance for Group revenues to decline by 10% to 15%"

Last time their outlook of 10% to 15% made no distinction for core brands, it was for group as a whole. Trying to move the goal posts after the match is no way to build trust. It's not until further down do they admit group revenues for the period actually declined by 17%.

Looks like Riot are slipping further down the league, Cipher (who are a bit underrated imo) outmined them last month

https://investors.ciphermining.com/news-releases/news-release-details/cipher-mining-announces-september-2023-operational-update

@pagey vote cut off is tomorrow, it's always a few days before meetings themselves to allow for share settlement. That's unless the company announce a postponement, which could happen but only if one of the other two bidders change their offers.